IMSTAR is pleased to announce that a key executive has joined its team to accelerate the growth of its worldwide business. Mr. Philippe Collard, has taken the position of Vice President, Corporate Development and, as such, will be responsible for expanding IMSTAR’s global business through distribution and licensing of its technology and products.
Philippe Collard has more than 20 years of experience managing and rapidly growing companies in various markets. He was the CEO of 3 high-tech companies, two of which were listed on a stock exchange. He was also the Chairman of a venture capital fund. He brings a wealth of experience in international business, marketing, sales and joint ventures to IMSTAR’s already impressive team. Philippe Collard will be based in Montreal (Canada).
Commenting on Philippe Collard’s appointment, Françoise Soussaline, President & CEO said: “We are very happy that an executive of Philippe’s caliber is now part of our team. We feel confident that, with his involvement, the penetration of our products in the cellular analysis market will quickly expand.”
Commenting on joining IMSTAR, Philippe Collard said: “The success to rapid expansion of a high-tech business is a growing market and available quality products to sell. IMSTAR has both. I am very excited to be part of the team and look forward to a lot of successful years with IMSTAR.”

IMSTAR (Paris, France) is a high-technology company offering complete vertical solutions for fully automated high-throughput (culture, smear, tissue section) cellular assays analysis in the fields of genetic toxicology for compound screening & bio-monitoring, clinical cytopathology & cytogenetic and drug discovery. IMSTAR’s team includes world experts in various scientific fields: automated systems, biophysics, physics, applied mathematics, cell biology and cytopathology.
IMSTAR was founded by Dr. Françoise Soussaline, President & CEO, as a spin-off of the Biology Department of the French Atomic Energy Commission (CEA) and incorporated in 1990. IMSTAR launched in 1997 the first automated, highly innovative and cost effective Image Cytometer based on its proprietary PathFinder™ Technology.
Over 1,000 Pathfinder™ systems have been installed in the world to date, including Europe, North America and Asia.

For more information, please contact:
93 boulevard Arago
Paris 75014, France
Tel: +33 (0)1 42 34 93 70
Fax: +33 (0)1 46 34 51 57